Patient-reported use of pancreatic enzyme replacement treatment (PERT) in pancreatic cancer in New Zealand and Australia: a cross-sectional survey study.
Amanda LandersHelen BrownJuhaina Al RuheiliKylie RussellClare McKenzieMeera R AgarVanessa M YensonKate ClarkeJohn WindsorPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2024)
PERT use in pancreatic cancer in New Zealand and Australia was highly variable and not compliant with international guidelines in which PERT is recommended as standard therapy. Enzyme replacement is effective for improving the symptoms of malabsorption in patients with pancreatic cancer. Clinician education may be needed to help improve the use of PERT in people with pancreatic cancer.